PTC Therapeutics | PTCT - Market Capitalization

Stock Price
71.47
Daily Change
-1.25 -1.72%
Monthly
-0.32%
Yearly
55.34%
Q2 Forecast
70.03

PTC Therapeutics reported $5.57B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.57B 221M May/2026
Alnylam Pharmaceuticals USD 44.15B 8.39B Mar/2026
Amgen USD 189.89B 13.64B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
BioMarin Pharmaceutical USD 10.18B 683M May/2026
Cytokinetics USD 9.16B 975M May/2026
Daiichi Sankyo JPY 6.34T 62.51B Dec/2025
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Esperion Therapeutics USD 885M 351M Dec/2025
Gilead Sciences USD 167.39B 5.6B May/2026
Incyte USD 21.73B 3B May/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
PTC Therapeutics USD 4.94B 698M May/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.16B 123M May/2026
TG Therapeutics USD 6.48B 1.18B May/2026
Ultragenyx Pharmaceutical USD 2.06B 1000K May/2026
Vertex Pharmaceuticals USD 113.58B 1000K May/2026
Xencor USD 795M 98M May/2026